Moolec Science SA Ordinary Shares

Moolec Science SA Ordinary Shares

MLEC · NASDAQ · Healthcare / Biotechnology

0.85USD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.85
Open0.85
Day Range0.85 – 0.85
52-Week Range3.08 – 23.22
Volume0
Market Cap3.58M
P/E (TTM)0.00
Forward P/E0.00
EPS-199.02
Dividend Yield0.00%
Beta-0.32
50-Day Avg6.89
200-Day Avg7.48

About

Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas. The company is based in Grand Cayman, Cayman Islands.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Alejandro Antalich
  • Employees0
  • Headquarters89 Nexus Way, Grand Cayman, Cayman Islands, KY1-9009, USA
  • Websitehttps://www.moolecscience.com

Leadership

  • Mr. Alejandro AntalichChief Executive Officer · b. 1974
  • Mr. Henk Hoogenkamp Ph.D.Co-Founder & Chief Product Officer · b. 1988
  • Mr. Martin Salinas Ph.D.Co-Founder · b. 1982
  • Ms. Valeria FalotticoChief Financial Officer · b. 1982
  • Dr. Paola Díaz DellavalleChief Technology Officer · b. 1976
  • Dr. Amit Dhingra Ph.D.Chief Science Officer · b. 1971
  • Ms. Catalina Jones B.A.Chief of Staff & Sustainability · b. 1987

Financials

Income Statement

Currency: USD2021-06-302022-06-302023-06-302024-06-302025-06-30
Total Revenue-0905.05K5.63M333.61M
Growth (%)---+521.53%+5830.74%
Cost of Revenue-01.05M5.15M219.61M
Gross Profit-0-143.31K472.58K114.01M
Gross Margin---15.83%8.40%34.17%
Operating Expense-1.72M6.51M9.52M124.48M
Operating Income-13.80K-1.72M-6.65M-9.04M-10.48M
Operating Margin---735.19%-160.76%-3.14%
EBITDA-13.80K-3.65M-51.74M-6.16M-69.01M
EBITDA Margin---5716.97%-109.50%-20.69%
Net Income-13.80K-4.53M-51.79M-7.31M-111.46M
Net Income Margin---5722.22%-129.99%-33.41%
R&D-985.16K1.35M1.77M9.24M
R&D as % of Total Revenue--149.11%31.51%2.77%
Interest Expense-2.13K160.03K1.17M41.81M
Interest Expense % of Total Revenue--17.68%20.72%12.53%

Balance Sheet

Currency: USD2021-06-302022-06-302023-06-302024-06-302025-06-30
Total Assets138.59M5.69M24.05M34.79M204.71M
Total Liabilities4.51M4.09M13.95M27.97M287.58M
Total Equity134.08M1.60M10.11M6.82M-65.97M
Cash337.60K1.08M2.53M5.39M767.92K
Total Debt125.00K125.00K2.65M14.68M246.88M
Net Debt-212.60K-956.81K117.62K9.29M246.11M

Cash Flow

Currency: USD2021-06-302022-06-302023-06-302024-06-302025-06-30
Operating Cash Flow-8.80K-915.08K-7.51M-9.33M-24.45M
Investing Cash Flow--138.00M-2.34M134.87K-35.99M
Financing Cash Flow14.49K139.05M11.28M11.71M13.07M
Capital Expenditure00179.19K158.28K5.65M
Free Cash Flow-8.80K-1.89M-7.69M-9.49M-30.10M
Dividends Paid-0000
FCF to OCF100.00%206.10%102.39%101.70%123.11%
Dividend Paid to FCF-0.00%0.00%0.00%0.00%

Earnings

Report DateMar 1, 2021Apr 15, 2021Jul 2, 2021Nov 22, 2021Dec 31, 2021Apr 12, 2022Aug 15, 2022Nov 9, 2022Mar 31, 2023Aug 30, 2023Oct 30, 2023Mar 13, 2024May 30, 2024Jun 30, 2024Oct 30, 2024Mar 12, 2025Apr 16, 2025Oct 27, 2025Mar 11, 2026
EPS Estimate0.00---------0.11-1.10-0.70-0.07-0.60-0.60-0.06-0.60-0.70-0.06
EPS Actual0.000.060.060.05-1.27-0.01-0.00-0.03-1.43-0.11-0.30-0.50-0.04-0.60-0.60-0.06-0.600.000.00
Surprise---------0.00%72.73%28.57%42.86%0.00%0.00%0.00%0.00%100.00%100.00%
Timing----------After-hoursAfter-hoursPre-market-After-hours-After-hours--

Key Statistics & Ratios

Market Cap3.58M
Enterprise Value69.95M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.01
Price / Book0.49
EPS-199.02
Book Value0.699
Revenue (TTM)7.83M
Gross Profit (TTM)-639.50K
EBITDA-8.07M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-174.68%
Return on Assets-21.69%
Shares Outstanding726.12K
Shares Float897.82K
Beta-0.32
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 1 analystsTarget 3.00
  • Buy
    1

Ownership Breakdown

Institutions
0.07%
Insiders
21.06%
Retail / Other
78.87%

Top Institutional Holders

  • HRT FINANCIAL LLC
    16.57K2.28%
  • UBS Group AG
    20.00%
  • SBI Securities Co Ltd
    10.00%

Top Fund Holders

  • Fidelity Nasdaq Composite Index
    7100.10%

Stock Splits

  • Jan 5, 20261:15
  • May 14, 20251:10